The basis for HIV immunotherapeutic vaccines
- 3 December 2001
- Vol. 20 (5-6) , 688-705
- https://doi.org/10.1016/s0264-410x(01)00394-2
Abstract
No abstract availableKeywords
This publication has 126 references indexed in Scilit:
- RNA‐based gene therapy for HIV infectionHIV Medicine, 2001
- A Therapeutic HIV Vaccine Using Coxsackie–HIV Recombinants: A Possible New StrategyAIDS Research and Human Retroviruses, 2000
- Induction of HIV‐1‐specific T‐helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co‐expressing interferon‐gammaJournal of Medical Primatology, 2000
- Antigen‐specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN‐γ, IL‐12, or IL‐18 gene adjuvantsJournal of Medical Primatology, 1999
- Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaquesEuropean Journal of Immunology, 1999
- CD8+ Lymphocyte Antiviral Activity in Monkeys Immunized with SIV Recombinant Poxvirus Vaccines: Potential Role in Vaccine EfficacyAIDS Research and Human Retroviruses, 1999
- In vivo protective anti‐HIV immune responses in non‐human primates through DNA immunizationJournal of Medical Primatology, 1996
- Potent inhibition of HIV-1 replication in vivo by a novel inhibitor of HIV-1 fusion: Michael A. Ussery, Owen L. Wood, Dennis D. Broud, Matthew A. Bacho, Steven C. Kunder, Susan F. Papermaster, Dennis M. Lambert1, Shawn Barney1, and Paul L. Black. U.S.F.D.A., Rockville, MD, and 1Trimeris, Inc., Research Triangle Park, NC, USAAntiviral Research, 1996
- Does the HIV envelope induce a chronic graft-versus-host-like disease?Immunology Today, 1992
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991